Richtlijnen

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van de HOVON Leukemie werkgroep.

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van het European LeukemiaNet.

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van het EU-MDS consortium.

Literatuur

  1. Döhner H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN - Blood 2022 - 140 (12): 1345-1377
  2. Arber D.A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical and genomic data - Arber et al. - Blood 2022 - 140 (11): 1200-1228
  3. Khoury et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic dendritic neoplasms - Leukemia 2022 - 36: 1703-1719
  4. Greenberg  PL et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454-2465
  5. Greenberg PL et al. International prognostic scoring system for myelodysplastic syndromes. Blood 1997; 89: 2079-2088
  6. Malcovati L et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013 122:2943-2964
  7. Cheson B.D. et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006, volume 108, number 2
  8. Bernard E. et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid 2022;1(7)
  9. Cremers E. et al. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes. Haematologica 2017; 102(2)320-326
  10. Ogata et al. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. Haematologica 2009; 94:1066-1074
  11. Westers et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia 2012; 26:170-1741
  12. Van de Loosdrecht et al. Cutting edge flow cytometry in myelo­dysplastic syndromes. J Natl Compr Canc Netw. 2013; 11:892-902
  13. Westers et al. Immunophenotypic analysis of erythroid dysplasia in myelo­dysplastic syndromes. A report from the IMDS Flow working group. Haematologica. 2017; 102:308-319

 

Ga terug naar de MDS homepage of lees meer over MDS:

Ga terug naar de algemene homepage Behandelprotocollen